Related Experiment Video
Updated: Jul 13, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Immunotherapy for prostate cancer - recent progress in clinical trials
Ryan T Kipp1, Douglas G McNeel
1University of Wisconson School of Medicine and Public Health, Madison, WI, USA.
Clinical Advances in Hematology & Oncology : H&O
|August 8, 2007
Summary
Prostate cancer immunotherapy shows promise for delaying disease progression with minimal side effects. Ongoing clinical trials are evaluating novel immune-modulating agents and combination therapies for advanced prostate cancer.
Area of Science:
- Oncology
- Immunology
- Urology
Background:
- Prostate cancer is a leading malignancy in the US, with localized disease often curable but metastatic disease currently incurable.
- Established treatments like androgen-deprivation therapy and chemotherapy for metastatic prostate cancer have significant side effects.
- Immunotherapy presents a promising avenue for novel prostate cancer treatments with potentially fewer adverse effects.
Purpose of the Study:
- To review recent clinical trials of immunotherapy for prostate cancer.
- To evaluate immune-modulating agents, antigen-specific active immunotherapy, and combination therapies.
- To assess the potential of immunotherapy in delaying disease progression in prostate cancer patients.
Main Methods:
- Review of recent clinical trials in prostate cancer immunotherapy.
- Evaluation of immune-modulating agents.
- Assessment of antigen-specific active immunotherapy and combination therapies.
Main Results:
- Early immunotherapy trials for prostate cancer have demonstrated minimal toxicity.
- Many trials suggest clinical benefits, including delayed disease progression.
- Several phase III trials are actively investigating treatments for metastatic, androgen-independent prostate cancer.
Conclusions:
- Immunotherapy offers a hopeful approach for managing advanced prostate cancer.
- Current research focuses on immune-modulating agents and combination therapies.
- Further investigation is warranted to optimize immunotherapy strategies for prostate cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...